Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PNMR in the Management of Long COVID
NCT07627815Phase 2Recruiting
- Sponsor
- Paragon Clinicals
- Start
- May 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in post-COVID-19 condition (PCC) (2 arms), sponsored by Paragon Clinicals. Primary endpoint: Change in distance walked on the 6-minute walk test at 6 weeks. Started May 2026; status: recruiting.
02
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT07627815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07627815.